Stem Cell Research - Market Trends, Investment Trends and Pipeline Analysis
Summary
GBI Research, the leading business intelligence provider, has released its latest research “Stem Cell Research - Market Trends, Investment Trends and Pipeline Analysis”. It is an essential source of information and analysis on global stem cell research and development. This pharmaceutical and healthcare report identifies the key trends shaping and driving stem cell research and development. The report analyses investment decisions within the stem cell research market by providing information on pipelines, federal spending, investor perspectives, regulatory environment, competitive landscape and market potential. The study also provides insight on the prevalent competitive landscape and the emerging players expected to significantly shift the market positioning. Most importantly, the report provides valuable insight on the pipeline products within the global stem cell industry.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.
Scope
The Scope of this report includes:
Reasons to buy
The report will enhance your decision making capability. It will allow you to:
Summary
GBI Research, the leading business intelligence provider, has released its latest research “Stem Cell Research - Market Trends, Investment Trends and Pipeline Analysis”. It is an essential source of information and analysis on global stem cell research and development. This pharmaceutical and healthcare report identifies the key trends shaping and driving stem cell research and development. The report analyses investment decisions within the stem cell research market by providing information on pipelines, federal spending, investor perspectives, regulatory environment, competitive landscape and market potential. The study also provides insight on the prevalent competitive landscape and the emerging players expected to significantly shift the market positioning. Most importantly, the report provides valuable insight on the pipeline products within the global stem cell industry.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.
Scope
The Scope of this report includes:
- Unmet needs and opportunity analysis for therapies that are currently in pipeline.
- Market characterization including market sizing, technology adoption framework and business models for the stem cell market.
- A cross-country analysis for regulatory framework, investments, research clusters and support including the US (United States), the UK (United Kingdom), Germany, France, Japan, China, India, Singapore, Canada and Australia
- In-depth information and analysis on the pipeline products expected to bring a shift in the market positions of the leading manufacturers.
- Analysis and review of the key events and milestones that will impact the future of the global stem cell market. Each trend independently researched to provide qualitative analysis of what the implications on sectors are, and how companies are responding to these trends.
- Insightful review of key industry drivers, restraints and challenges which are likely to impact the global stem cell research and development in the long run.
- Information on the leading market players and the prevailing competitive landscape. Key companies covered include Osiris Therapeutics, Aastrom Biosciences, Cytori Therapeutics, Pluristem Therapeutics and Geron.
Reasons to buy
The report will enhance your decision making capability. It will allow you to:
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying companies with the most robust pipelines
- Develop business strategies by understanding the trends shaping and driving stem cell research and development.
- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the stem cell market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships
- What’s the next big thing in the stem cell research and development landscape? – Identify, understand and capitalize.
1.1 List of Tables
1.2 List of Figures
2 INTRODUCTION
2.1 GBI Research Report Guidance
3 MARKET OVERVIEW
3.1 Stem Cell Research – An Introduction
3.2 Types of Stem Cell Research
3.3 Unmet Needs
3.4 Applications of Stem Cell Research
4 MARKET CHARACTERIZATION
4.1 Stem Cell Market – An Introduction
4.2 Market Sizing
4.3 Therapy cost
4.4 Technology Adoption Framework
4.5 Types of Business Models
4.6 Market Drivers
4.6.1 Supporting Political Environment on Embryonic Stem Cell Research will Advance the Stem Cell Industry to Prosper in the United States
4.6.2 Limited Availability of Treatments to Treat Certain Disease Conditions Increases Market Opportunity for Stem Cell Research
4.7 Market Barriers & Challenges
4.7.1 Stem Cell Research and Development is an expensive process which requires considerable funding to be operational.
4.7.2 Availability of Adequate Reimbursements are Unclear and leads to a conundrum
4.7.3 Ethical, legal and social issues persists and acts as a challenge
4.7.4 Identifying, recruiting and retaining the best scientific talents is an intractable process for stem cell research based companies
4.8 Stem Cell Research and Development - Market Trends
4.8.1 Booming Stem Cell Tourism is a Potential Opportunity for Countries to Attract Investments.
4.8.2 ASLAP Analysis of Stem Cell Tourism
4.8.3 Federal Funding Support Improves the Stem Cell Research Environment
4.8.4 Increasing Entry of Pharmaceutical Companies Boosts Stem Cell Research & Development
4.8.5 PESTLE Analysis
4.8.6 SWOT Analysis of Stem Cell Research & Development
4.9 Industry Analysis
5 STEM CELL RESEARCH AND DEVELOPMENT - PIPELINE ANALYSIS
5.1 Pipeline by Various Phases
5.2 Phase III Pipeline Analysis
5.3 Phase II Pipeline Analysis
5.4 Preclinical and Phase 1 Pipeline
6 STEM CELL RESEARCH AND DEVELOPMENT - INVESTMENT TRENDS
6.1 Investor’s Perspective on Stem Cell Research
6.2 NIH spending in Stem Cell Research and Development is Increasing and is Supportive
6.2.1 NIH Spending by Stem Cell Research Type
6.2.2 High Budget Projects Funded by NIH
6.3 States Funding on Stem Cell Research in the US is in Reconsideration.
6.4 R&D Spending by Stem Cell Research Companies
7 STEM CELL RESEARCH AND DEVELOPMENT - GEOGRAPHICAL TRENDS
7.1 Stem Cell Companies by Geographic Regions
7.2 The United States
7.3 United Kingdom
7.4 China
7.5 Netherlands
7.6 Singapore
7.7 South Korea
7.8 Japan
7.9 India
7.10 Sweden
7.11 Denmark
7.12 France
7.13 Germany
7.14 Israel
7.15 Australia
7.16 Canada
7.17 Czech Republic
8 STEM CELL RESEARCH AND DEVELOPMENT - MERGERS AND ACQUISITIONS
9 STEM CELL RESEARCH AND DEVELOPMENT - COMPETITIVE STRUCTURE
9.1 Stem Cell Companies by Therapy Areas
9.2 Stem Cell Companies by Stem Cell Types
10 STEM CELL RESEARCH AND DEVELOPMENT - COMPANY PROFILES
10.1 Aastrom Biosciences
10.2 Osiris Therapeutics
10.3 Bioheart
10.4 Aldagen
10.5 Mesoblast
10.6 Geron
10.7 Advanced Cell Technology
10.8 Cytori Therapeutics
10.9 Pluristem Therapeutics
10.10 Medistem
10.11 Neostem
11 STEM CELL RESEARCH AND DEVELOPMENT - CONCLUSION
12 APPENDIX
12.1 Market Definitions
12.2 Key Support Data
12.3 Abbreviations
12.4 Methodology
12.4.1 Coverage
12.4.2 Secondary Research
12.4.3 Primary Research
12.4.4 Expert Panels
12.5 Contact Us
12.6 Disclaimer
1.1 LIST OF TABLES
Table 1: Disease Conditions and Population in US
Table 2: Preferred Countries for Stem Cell Tourism
Table 3: Pharmaceutical Companies Partnership Environment
Table 4: Phase III Pipeline
Table 5: Phase II Pipeline
Table 6: Preclinical and Phase 1 Pipelines
Table 7: NIH Spending
Table 8: Spending of States in US on Stem Cell Research
Table 9: Mergers and Acquisitions in Stem Cell Research
Table 10: Aastrom Biosciences
Table 11: Osiris Therapeutics
Table 12: BioHeart
Table 13: Aldagen
Table 14: Mesoblast
Table 15: Geron
Table 16: Advanced Cell Technology
Table 17: Cytori Therapeutics
Table 18: Pluristem Therapeutics
Table 19: Medistem
Table 20: Neostem
1.2 LIST OF FIGURES
Figure 1: Stem Cell Research and Development Segmentation
Figure 2: Stem Cells – Interaction Framework
Figure 3: Cells Models –Present and the Future
Figure 4: Unmet Need Vs Time to Market
Figure 5: Adult Stem Cells – Applications
Figure 6: Technology Adoption Framework
Figure 7: Business Models in Stem Cell Industry
Figure 8: Political Environnent – Impact Analysis
Figure 9: Treatment Availability – Impact Analysis
Figure 10: Cost of Research – Impact Analysis
Figure 11: Reimbursements – Impact Analysis
Figure 12: Ethical, legal and Social Issues – Impact Analysis
Figure 13: Human Resources – Impact Analysis
Figure 14: ASLAP Analysis of Stem Cell Tourism
Figure 15: Stem Cell Research- Federal Funding Trend
Figure 16: PESTLE Analysis of Stem Cell Research
Figure 17: SWOT Analysis of Stem Cell Research and Development
Figure 18: SWOT Analysis of Stem Cell Research and Development – Impact Grid
Figure 19: Five Force Analysis
Figure 20: Stem Cell Development Pipeline by Clinical Trial Phase
Figure 21: VC’s Perspective on Stem Cell Research
Figure 22: VC’s Perspective on Stem Cell Research – Impact Analysis
Figure 23: NIH Spending by Stem cell Research Type
Figure 24: High Budget Projects Funded by NIH
Figure 25: R&D Spending by Public Companies
Figure 26: Stem Cell Companies by Geographic Regions
Figure 27: Country Analysis – United States
Figure 28: Country Analysis – United Kingdom
Figure 29: Country Analysis – China
Figure 30: Country Analysis – Netherlands
Figure 31: Country Analysis – Singapore
Figure 32: Country Analysis – South Korea
Figure 33: Country Analysis – Japan
Figure 34: Country Analysis – India
Figure 35: Country Analysis – Sweden
Figure 36: Country Analysis – Denmark
Figure 37: Country Analysis – France
Figure 38: Country Analysis – Germany
Figure 39: Country Analysis – Israel
Figure 40: Country Analysis – Australia
Figure 41: Country Analysis – Canada
Figure 42: Country Analysis – Czech Republic
Figure 43: Mergers and Acquisitions – Year wise Analysis
Figure 44: Stem Cell Companies by Therapy Areas
Figure 45: Stem Cell Companies by Stem Cell Types
Figure 46: GBI Research Methodology
COMPANIES MENTIONED
Aastrom Biosciences
Osiris Therapeutics
Bioheart
Aldagen
Mesoblast
Geron
Advanced Cell Technology
Cytori Therapeutics
Pluristem Therapeutics
Medistem
Neostem
1.2 List of Figures
2 INTRODUCTION
2.1 GBI Research Report Guidance
3 MARKET OVERVIEW
3.1 Stem Cell Research – An Introduction
3.2 Types of Stem Cell Research
3.3 Unmet Needs
3.4 Applications of Stem Cell Research
4 MARKET CHARACTERIZATION
4.1 Stem Cell Market – An Introduction
4.2 Market Sizing
4.3 Therapy cost
4.4 Technology Adoption Framework
4.5 Types of Business Models
4.6 Market Drivers
4.6.1 Supporting Political Environment on Embryonic Stem Cell Research will Advance the Stem Cell Industry to Prosper in the United States
4.6.2 Limited Availability of Treatments to Treat Certain Disease Conditions Increases Market Opportunity for Stem Cell Research
4.7 Market Barriers & Challenges
4.7.1 Stem Cell Research and Development is an expensive process which requires considerable funding to be operational.
4.7.2 Availability of Adequate Reimbursements are Unclear and leads to a conundrum
4.7.3 Ethical, legal and social issues persists and acts as a challenge
4.7.4 Identifying, recruiting and retaining the best scientific talents is an intractable process for stem cell research based companies
4.8 Stem Cell Research and Development - Market Trends
4.8.1 Booming Stem Cell Tourism is a Potential Opportunity for Countries to Attract Investments.
4.8.2 ASLAP Analysis of Stem Cell Tourism
4.8.3 Federal Funding Support Improves the Stem Cell Research Environment
4.8.4 Increasing Entry of Pharmaceutical Companies Boosts Stem Cell Research & Development
4.8.5 PESTLE Analysis
4.8.6 SWOT Analysis of Stem Cell Research & Development
4.9 Industry Analysis
5 STEM CELL RESEARCH AND DEVELOPMENT - PIPELINE ANALYSIS
5.1 Pipeline by Various Phases
5.2 Phase III Pipeline Analysis
5.3 Phase II Pipeline Analysis
5.4 Preclinical and Phase 1 Pipeline
6 STEM CELL RESEARCH AND DEVELOPMENT - INVESTMENT TRENDS
6.1 Investor’s Perspective on Stem Cell Research
6.2 NIH spending in Stem Cell Research and Development is Increasing and is Supportive
6.2.1 NIH Spending by Stem Cell Research Type
6.2.2 High Budget Projects Funded by NIH
6.3 States Funding on Stem Cell Research in the US is in Reconsideration.
6.4 R&D Spending by Stem Cell Research Companies
7 STEM CELL RESEARCH AND DEVELOPMENT - GEOGRAPHICAL TRENDS
7.1 Stem Cell Companies by Geographic Regions
7.2 The United States
7.3 United Kingdom
7.4 China
7.5 Netherlands
7.6 Singapore
7.7 South Korea
7.8 Japan
7.9 India
7.10 Sweden
7.11 Denmark
7.12 France
7.13 Germany
7.14 Israel
7.15 Australia
7.16 Canada
7.17 Czech Republic
8 STEM CELL RESEARCH AND DEVELOPMENT - MERGERS AND ACQUISITIONS
9 STEM CELL RESEARCH AND DEVELOPMENT - COMPETITIVE STRUCTURE
9.1 Stem Cell Companies by Therapy Areas
9.2 Stem Cell Companies by Stem Cell Types
10 STEM CELL RESEARCH AND DEVELOPMENT - COMPANY PROFILES
10.1 Aastrom Biosciences
10.2 Osiris Therapeutics
10.3 Bioheart
10.4 Aldagen
10.5 Mesoblast
10.6 Geron
10.7 Advanced Cell Technology
10.8 Cytori Therapeutics
10.9 Pluristem Therapeutics
10.10 Medistem
10.11 Neostem
11 STEM CELL RESEARCH AND DEVELOPMENT - CONCLUSION
12 APPENDIX
12.1 Market Definitions
12.2 Key Support Data
12.3 Abbreviations
12.4 Methodology
12.4.1 Coverage
12.4.2 Secondary Research
12.4.3 Primary Research
12.4.4 Expert Panels
12.5 Contact Us
12.6 Disclaimer
1.1 LIST OF TABLES
Table 1: Disease Conditions and Population in US
Table 2: Preferred Countries for Stem Cell Tourism
Table 3: Pharmaceutical Companies Partnership Environment
Table 4: Phase III Pipeline
Table 5: Phase II Pipeline
Table 6: Preclinical and Phase 1 Pipelines
Table 7: NIH Spending
Table 8: Spending of States in US on Stem Cell Research
Table 9: Mergers and Acquisitions in Stem Cell Research
Table 10: Aastrom Biosciences
Table 11: Osiris Therapeutics
Table 12: BioHeart
Table 13: Aldagen
Table 14: Mesoblast
Table 15: Geron
Table 16: Advanced Cell Technology
Table 17: Cytori Therapeutics
Table 18: Pluristem Therapeutics
Table 19: Medistem
Table 20: Neostem
1.2 LIST OF FIGURES
Figure 1: Stem Cell Research and Development Segmentation
Figure 2: Stem Cells – Interaction Framework
Figure 3: Cells Models –Present and the Future
Figure 4: Unmet Need Vs Time to Market
Figure 5: Adult Stem Cells – Applications
Figure 6: Technology Adoption Framework
Figure 7: Business Models in Stem Cell Industry
Figure 8: Political Environnent – Impact Analysis
Figure 9: Treatment Availability – Impact Analysis
Figure 10: Cost of Research – Impact Analysis
Figure 11: Reimbursements – Impact Analysis
Figure 12: Ethical, legal and Social Issues – Impact Analysis
Figure 13: Human Resources – Impact Analysis
Figure 14: ASLAP Analysis of Stem Cell Tourism
Figure 15: Stem Cell Research- Federal Funding Trend
Figure 16: PESTLE Analysis of Stem Cell Research
Figure 17: SWOT Analysis of Stem Cell Research and Development
Figure 18: SWOT Analysis of Stem Cell Research and Development – Impact Grid
Figure 19: Five Force Analysis
Figure 20: Stem Cell Development Pipeline by Clinical Trial Phase
Figure 21: VC’s Perspective on Stem Cell Research
Figure 22: VC’s Perspective on Stem Cell Research – Impact Analysis
Figure 23: NIH Spending by Stem cell Research Type
Figure 24: High Budget Projects Funded by NIH
Figure 25: R&D Spending by Public Companies
Figure 26: Stem Cell Companies by Geographic Regions
Figure 27: Country Analysis – United States
Figure 28: Country Analysis – United Kingdom
Figure 29: Country Analysis – China
Figure 30: Country Analysis – Netherlands
Figure 31: Country Analysis – Singapore
Figure 32: Country Analysis – South Korea
Figure 33: Country Analysis – Japan
Figure 34: Country Analysis – India
Figure 35: Country Analysis – Sweden
Figure 36: Country Analysis – Denmark
Figure 37: Country Analysis – France
Figure 38: Country Analysis – Germany
Figure 39: Country Analysis – Israel
Figure 40: Country Analysis – Australia
Figure 41: Country Analysis – Canada
Figure 42: Country Analysis – Czech Republic
Figure 43: Mergers and Acquisitions – Year wise Analysis
Figure 44: Stem Cell Companies by Therapy Areas
Figure 45: Stem Cell Companies by Stem Cell Types
Figure 46: GBI Research Methodology
COMPANIES MENTIONED
Aastrom Biosciences
Osiris Therapeutics
Bioheart
Aldagen
Mesoblast
Geron
Advanced Cell Technology
Cytori Therapeutics
Pluristem Therapeutics
Medistem
Neostem